Abstract:The human immunodeficiency virus type 1 (HIV-1) reservoir consists of latently infected cells which present a major obstacle to achieving a functional cure for HIV-1. The formation and maintenance of HIV-1 latency have been extensively studied, and latency-reversing agents (LRAs) that can reactivate latent HIV-1 by targeting the involved host factors are developed; however, their clinical efficacies remain unsatisfactory. Therefore, it is imperative to identify novel targets for more potential candidates or better combinations for LRAs. In this study, we utilized CRISPR affinity purification in situ of regulatory elements system to screen for host factors associated with the HIV-1 long terminal repeat region that could potentially be involved in HIV-1 latency. We successfully identified that origin recognition complex 1 (ORC1), the largest subunit of the origin recognition complex, contributes to HIV-1 latency in addition to its function in DNA replication initiation. Notably, ORC1 is enriched on the HIV-1 promoter and recruits a series of repressive epigenetic elements, including DNMT1 and HDAC1/2, and histone modifiers, such as H3K9me3 and H3K27me3, thereby facilitating the establishment and maintenance of HIV-1 latency. Moreover, the reactivation of latent HIV-1 through ORC1 depletion has been confirmed across various latency cell models and primary CD4+ T cells from people living with HIV-1. Additionally, we comprehensively validated the properties of liquid-liquid phase separation (LLPS) of ORC1 from multiple perspectives and identified the key regions that promote the formation of LLPS. This property is important for the recruitment of ORC1 to the HIV-1 promoter. Collectively, these findings highlight ORC1 as a potential novel target implicated in HIV-1 latency and position it as a promising candidate for the development of novel LRAs. Importance: Identifying host factors involved in maintaining human immunodeficiency virus type 1 (HIV-1) latency and understanding their mechanisms prepares the groundwork to discover novel targets for HIV-1 latent infection and provides further options for the selection of latency-reversing agents in the "shock" strategy. In this study, we identified a novel role of the DNA replication factor origin recognition complex 1 (ORC1) in maintaining repressive chromatin structures surrounding the HIV-1 promoter region, thereby contributing to HIV-1 latency. This discovery expands our understanding of the non-replicative functions of the ORC complex and provides a potential therapeutic strategy for HIV-1 cure.

The Per-1 short isoform inhibits de novo HIV-1 transcription in resting CD4+ T-cells.

Identification of CD98 As a Novel Biomarker for HIV-1 Permissiveness and Latent Infection

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat

RPLP1 Restricts HIV-1 Transcription by Disrupting C/EBPβ Binding to the LTR

MCPIP1 Restricts HIV Infection and is Rapidly Degraded in Activated CD4+ T Cells

Effect of transcription inhibition and generation of suppressive viral non-coding RNAs

Proteomic profiling of HIV-1 infection of human CD4 + T cells identifies PSGL-1 as an HIV restriction factor

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes

Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages

FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency*

PEBP 1 suppresses HIV transcription and induces latency by inactivating MAPK / NF ‐κB signaling

Inhibition of the TRIM24 bromodomain reactivates latent HIV-1

Neuropilin-1, a Myeloid Cell-Specific Protein, is an Inhibitor of HIV-1 Infectivity.

Prohibitin1 facilitates viral replication by impairing the RIG-I-like receptor signaling pathway

Epigenetic silencing and blockade of latency reversal by an HIV-1 encoded antisense transcript

A New Small-Molecule Compound, Q308, Silences Latent HIV-1 Provirus by Suppressing Tat- and FACT-Mediated Transcription.

Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence

ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency

Immune Regulator Abin1 Suppresses Hiv-1 Transcription by Negatively Regulating the Ubiquitination of Tat